
Sign up to save your podcasts
Or


Attorneys Brady Bizarro and Andrew Silverio discuss today’s senate committee hearing on GLP-1 drug pricing and strategies that self-funded employers are using to manage the extreme costs of these drugs while we wait and hope for congressional action.
By The Phia Group4.9
1717 ratings
Attorneys Brady Bizarro and Andrew Silverio discuss today’s senate committee hearing on GLP-1 drug pricing and strategies that self-funded employers are using to manage the extreme costs of these drugs while we wait and hope for congressional action.

32,130 Listeners

30,626 Listeners

30,218 Listeners

233 Listeners

20 Listeners

112,333 Listeners

1,084 Listeners

29 Listeners

44,138 Listeners

35 Listeners

10,259 Listeners

15 Listeners

0 Listeners

801 Listeners